Stay updated on CD19/22 CAR T Cells in DLBCL Clinical Trial

Sign up to get notified when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD19/22 CAR T Cells in DLBCL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov site revision identifier changes from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T01:14:04.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the AUTO3 study in relapsed or refractory diffuse large B-cell lymphoma is displayed, including its terminated status, study details, eligibility criteria, outcomes, and results.
    Difference
    65%
    Check dated 2026-11-10T20:30:09.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T21:25:00.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:53:27.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-06T20:43:06.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error page with a header and a Home button, replacing the detailed study information. This indicates the study record is currently inaccessible on ClinicalTrials.gov.
    Difference
    20%
    Check dated 2026-09-22T23:25:27.000Z thumbnail image

Stay in the know with updates to CD19/22 CAR T Cells in DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.